Bedrest may affect cholesterol dynamics differently depending on age
A new study examining cholesteryl esters suggests that periods of prolonged inactivity may affect people differently depending on their age. Cholesteryl esters — which consist of cholesterol molecules bonded with fatty acids — store and transport cholesterol throughout the body.
As people get older, their risk of being hospitalized or bedridden increases. These long periods of inactivity come with a host of negative health effects such as reduced insulin function and loss of lean muscle, bone mass and strength. Scientists are working to better understand the biology involved in these changes so that therapies can be developed that reduce the negative consequences of physical inactivity.
Trevor Romsdahl, a research scientist at the University of Texas Medical Branch in Galveston, led a recent study.
“We measured the cholesteryl esters from blood plasma collected during bed-rest studies focused on middle-aged and older adults,” he said. “To our knowledge no study has measured the specific molecular species of cholesteryl esters during a bedrest study. Most other work has focused on measuring low-density lipoprotein and high-density lipoprotein cholesterol concentrations.”
Romsdahl will present the research at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, which is being held March 23–26 in San Antonio.
Cholesteryl esters are important in key biological processes such as lipid metabolism, cellular function and overall maintenance of health. Dysregulation of cholesteryl ester metabolism can play a role in the development of cardiovascular diseases and metabolic disorders.
“There's very little information on the biological significance of cholesteryl esters with different fatty acids, which differ in terms of chain length and degrees of unsaturation,” Romsdahl said. “Also, much of the research examining cholesterol changes and bed rest has been done in younger adults.”
For the new study, Romsdahl’s team partnered with Emily J. Arentson–Lantz, an assistant professor at the University of Texas Medical Branch, to analyze plasma samples she acquired in bed-rest studies that were focused on middle-aged and older adults. To measure specific molecular species of cholesteryl esters, the team developed a sensitive analysis method based on liquid chromatography and tandem mass spectrometry. It involved using a highly hydrophobic C30 liquid chromatography column to separate different cholesteryl ester species based on what fatty acid they contained.
The analysis showed that during bed rest several cholesteryl esters tended to increase in middle-aged subjects but decrease in older adults. However, the researchers observed similar changes in middle-aged and older adults when post-recovery levels were compared with pre–bed-rest levels.
“More research is needed to better understand the biological significance of these results and what effect they may have on health,” Romsdahl said. “However, it is possible that altering or supplementing meals with certain fatty acids versus others could subtly shift the cholesteryl ester species to a healthier profile.”
Trevor Romsdahl will present this research during a poster session from 4:30 to 6:30 p.m. CDT on Sunday, March 24, in the exhibit hall of the Henry B. González Convention Center (Poster Board No. 335) (abstract).
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Cholesterol regulatory genes predict liver transplant outcomes
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.

Catching tau in the act
Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.